Literature DB >> 7986372

Behavioral sensitization to drug stimulant effects in C57BL/6J and DBA/2J inbred mice.

T J Phillips1, S Dickinson, S Burkhart-Kasch.   

Abstract

Common features shared by addictive drugs have been difficult to identify. One ubiquitous effect of these drugs is psychomotor stimulation. Further, repeated exposure commonly results in sensitization to drug stimulant effects. This study evaluates sensitization to drugs from several drug classes in C57BL/6J and DBA/2J inbred strain mice. DBA/2J mice showed sensitized responses to ethanol and methamphetamine, whereas C57BL/6J mice developed sensitization to morphine and methamphetamine. Strain susceptibilities to ethanol- and morphine-induced sensitization closely paralleled their sensitivities to the acute stimulant effects of these drugs; this was not the case for methamphetamine. The relative sensitivities of DBA/2J and C57BL/6J mice were not consistent across drugs, suggesting that the stimulant and sensitized responses to these drugs may be mediated by at least partially divergent neural mechanisms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7986372     DOI: 10.1037//0735-7044.108.4.789

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  76 in total

1.  Repeated maternal separation: differences in cocaine-induced behavioral sensitization in adult male and female mice.

Authors:  Takefumi Kikusui; Sara Faccidomo; Klaus A Miczek
Journal:  Psychopharmacology (Berl)       Date:  2004-08-21       Impact factor: 4.530

2.  Dissociation of corticotropin-releasing factor receptor subtype involvement in sensitivity to locomotor effects of methamphetamine and cocaine.

Authors:  William J Giardino; Gregory P Mark; Mary P Stenzel-Poore; Andrey E Ryabinin
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

3.  A genetic animal model of differential sensitivity to methamphetamine reinforcement.

Authors:  Shkelzen Shabani; Lauren K Dobbs; Matthew M Ford; Gregory P Mark; Deborah A Finn; Tamara J Phillips
Journal:  Neuropharmacology       Date:  2012-01-20       Impact factor: 5.250

4.  Meal schedule influences food restriction-induced locomotor sensitization to methamphetamine.

Authors:  Amanda L Sharpe; Joshua D Klaus; Michael J Beckstead
Journal:  Psychopharmacology (Berl)       Date:  2011-07-13       Impact factor: 4.530

5.  Does context influence the duration of locomotor sensitization to ethanol in female DBA/2J mice?

Authors:  Stephen L Boehm; Karen J Goldfarb; Kristen M Serio; Eileen M Moore; David N Linsenbardt
Journal:  Psychopharmacology (Berl)       Date:  2007-11-30       Impact factor: 4.530

6.  The alpha2-adrenoceptor antagonist atipamezole reduces the development and expression of d-amphetamine-induced behavioural sensitization.

Authors:  Juuso Juhila; Antti Haapalinna; Jouni Sirviö; Jukka Sallinen; Aapo Honkanen; Esa R Korpi; Mika Scheinin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-14       Impact factor: 3.000

7.  Genetic factors involved in risk for methamphetamine intake and sensitization.

Authors:  John K Belknap; Shannon McWeeney; Cheryl Reed; Sue Burkhart-Kasch; Carrie S McKinnon; Na Li; Harue Baba; Angela C Scibelli; Robert Hitzemann; Tamara J Phillips
Journal:  Mamm Genome       Date:  2013-11-13       Impact factor: 2.957

8.  Adolescent low-dose ethanol drinking in the dark increases ethanol intake later in life in C57BL/6J, but not DBA/2J mice.

Authors:  Jennifer T Wolstenholme; Rabha M Younis; Wisam Toma; M Imad Damaj
Journal:  Alcohol       Date:  2020-08-26       Impact factor: 2.405

9.  Stress and Rodent Models of Drug Addiction: Role of VTA-Accumbens-PFC-Amygdala Circuit.

Authors:  Jasmine J Yap; Klaus A Miczek
Journal:  Drug Discov Today Dis Models       Date:  2008

Review 10.  Behavioral genetic contributions to the study of addiction-related amphetamine effects.

Authors:  Tamara J Phillips; Helen M Kamens; Jeanna M Wheeler
Journal:  Neurosci Biobehav Rev       Date:  2007-11-29       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.